In many countries, people still do not have access to the medicines they need in order to ensure an acceptable state of health. Switzerland is committed to facilitate access to medicines while safeguarding the protection of intellectual property rights which are drivers for research and innovation.
Dementia, which includes Alzheimer's disease, affects an increasing number of people in the world every year. While Switzerland has a national dementia strategy, a large number of countries still do not consider this pandemic to be a priority.
Drawing on experience, Switzerland belongs to the countries that are promoting approaches to public health, and that place the human dimension firmly at the centre of national and international drug policy.
Alcohol, smoking, a lack of exercise and poor diet are the main causes of chronic diseases, both in Switzerland and worldwide. In this area, Switzerland’s activities are aligned with WHO’s global and European action plans.
A number of health threats call for cooperation between different countries. Switzerland applies the International Health Regulations and the action plan against antimicrobial resistance drawn up by the WHO to this end. It also participates in the Global Health Security Agenda.
The quality of healthcare offered depends very much on the available health workers and, in particular, on health workers from abroad. These migrations, however, lead to shortages in the departure country. A growing global awareness has prompted action in this respect, and Switzerland has contributed to these measures on both international and national level.
Switzerland uses comparisons and analyses to identify the strengths, weaknesses and challenges of its health system. Switzerland is involved in a number of international bodies whose task is to facilitate inter-system comparisons.
Almost half of the world’s population has no access to essential health services. Each year nearly hundred million people face extreme poverty because of the money they have to spend on health services.